and mediated by a circulating GH-dependent factor now known as somatomedin-C or insulin-like growth factor I (Sm-C/IGF-I). The postulate that the stimulatory effects of growth hormone on skeletal growth are somatomedin-mediated arose from this and other early work (2, 3) and has come to be known as the somatomedin hypothesis. Most studies investigating the relationships between GH, somatomedin, cartilage, and growth have supported this hypothesis (1-12). In contrast, recent data suggest that the action of GH on chondrocytes is a direct one (13) (14) (15) (16) (17) (18) (19) . As a result, the mechanism by which these hormonal factors regulate skeletal growth has become controversial.
Several in vivo studies have demonstrated longitudinal limb growth in rats receiving hGH injected directly into the tibia1 growth plate (13, 16) or the limb vasculature (19) . Perhaps the most compelling evidence for a direct effect of GH on cartilage is the finding by Madsen et al. (14) that proliferation of cultured lapine ear and rib chondrocytes in culture is stimulated by hGH. The results of these studies are consistent with a direct GH effect, but are also consistent with an indirect effect of GH mediated by local GH-dependent somatomedin production. Such an autocrine or paracrine model for stimulation of growth has received support from several lines of experimental evidence (20, 21) .
Green et al. (22) have recently proposed an alternative model for GH and Sm-C/IGF-I actions in which GH promotes differentiation of stem cells, rendering them responsive to stimulation of proliferation by Sm-C/IGF-I. Although support for this dual effector theory has been obtained for certain cell types (23) , its application to skeletal growth has not been established.
To characterize the respective effects of Sm-C/IGF-I and GH on both articular and growth plate cartilage, the present studies sought first to reproduce the "direct" in vitro GH effect on physeal and articular chondrocytes to determine whether this effect is mediated by somatomedin in a local autocrine or paracrine fashion. If direct, any observed GH action would be expected to be unaffected by experimental conditions influencing autocrine or paracrine Sm-C/IGF-I actions (24, 25) . These studies also addressed the question whether, as predicted by the dual effector theory, chondrocytes at different stages of maturational development or anatomic derivation buffer with respect to Sm-C/IGF-I or GH responsiveness.
Our data indicate that GH does not directly stimulate rabbit articular or physeal chondrocytes or bovine phiseal chondrocytes In 1957, Salmon and Daughada~ SM-C/IGF-I AND GH EFFE( 2T ON CHONDROCYTES
MATERIALS AND METHODS
Hormones and growth factors. In bovine chondrocyte studies, highly purified preparations of Sm-C/IGF-I were the gift of Dr. Judson J. Van Wyk (Chapel Hill, NC). The Sm-C/IGF-I content of these preparations was determined by RIA (26) . For rabbit chondrocytes studies, Sm-C/IGF-I was a gift of Dr. Leo Van den Brande (Utrecht, The Netherlands). hGH for bovine studies was the gift of Dr. Linda Frykland, KABI-AB (Stockholm, Sweden), and hGH for rabbit studies was purchased from Nordisk (2 IU/ mg) (Gentoffe, Denmark). Met-rhGH for bovine studies was the gift of Dr. Christopher Rudman, Genentech, Inc. (South San Francisco, CA), and for rabbit studies was obtained from Serono (Geneva, Switzerland). bGH was the gift of the National Hormone and Pituitary Program (Baltimore, MD).
Bovine physeal chondrocyte culture. Growth plate chondrocytes were isolated from the fresh (approximately 2 h postmortem) physes of 1 -to 2-wk-old calves by modification of previously described techniques (7) . After sterile preparation of the distal radius, the distal radial physis was dissected from surrounding bone, and the perichondrium was completely excised. The harvested cartilage was diced in DMEM, and cells were isolated by sequential exposure to DMEM containing 0.08 hyaluronidase (Sigma Chemical Co., St. Louis, MO) for 20 min, 0.2% trypsin (Worthington Biochemicals, Freehold, NH) for 40 min, and 0.1 % collagenase (Sigma) with 5% calf serum (GIBCO, Grand Island, NY) overnight. Cells were filtered through nylon mesh (pore size, 125 pm) to remove matrix debris and cell aggregates. The cell suspension (approximately 0.5 x lo6 cells/ml) was layered in 20-ml aliquots onto 11 ml Ficoll/Hypaque (lo%/ 1 1 %) in 50-ml centrifuge tubes. After centrifugation at 200 X g for 6 min to remove undigested matrix fragments, the cells were recovered from the medium-gradient interface, washed once in PBS, pH 7.4, and resuspended in a 1: 1 (vo1:vol) mixture of F-12 medium (GIBCO) and DMEM containing 10% heat-inactivated newborn calf serum (GIBCO), 50 pglml L-ascorbate, 50 U/ml penicillin G, and 50 pg/ml streptomycin sulfate. Cell number was determined by a hemocytometer and viability by trypan blue exclusion.
To test the effect of GH on these physeal chondrocytes, the method of Madsen et al. (14) was used. Cells were plated at 3 x lo5 cells/cm2 in triplicate or quadruplicate 24-or 96-well plates and incubated overnight at 37°C in an atmosphere of air containing 5% C02 to allow cell attachment. The next day, the medium was changed to serum-free MCDB-104 medium (GIBCO) containing 100 pg/ml gentamycin and cells preincubated for 24-48 h. After preincubation, medium was changed to MCBD-104 containing GH, Sm-C/IGF-I, serum, or no additives as designated. At 6 or 24 h before the end of incubation, 8 pCi/ ml [3H]thymidine (New England Nuclear, Boston, MA) was added to the medium. Cells were washed 3 x with PBS, pH 7.4, and 2 x with 5% trichloroacetic acid and 3:l (vo1:vol) ethanol/ ethyl ether. Isotope incorporation was determined by liquid scintillation counting of solubilized cells or by whole mount autoradiography of cells fixed in situ in a solution of 3% glutaraldehyde, 0.1% M sodium cacdylate-HC1 and 0.05 M sucrose, pH 7.3.
Statistical analysis of data was performed with the two-tailed F-test using the Statistical Analysis System package provided by the Massachusetts General Hospital Department of Biostatistics.
Rabbit chondrocyte culture. Prepubertal Fauve de Bourgogne rabbits (Ruvel, France) were killed by a sharp blow on the head and shaved. After several washings with 70% alcohol, a section of ventral skin was taken and long bones were quickly removed. Muscles, aponeurosis, and periosteum were removed from the bones, and articular and growth plate cartilage were harvested. Cartilage slices and the sample of ventral skin were further cut into small pieces. Tissues were then subjected to enzymatic digestion by a modification of the above cell isolation procedure (27) . The resulting cell suspension was plated into 25-cm2 flasks at a concentration of 8 x lo4 cells/flask in 4 ml Ham's F12 medium containing 10% FCS (Boehringer Mannheim), 100 IU/ ml penicillin and 100 pg/ml streptomycin or into 24-well plates at a concentration of 1 x lo4 cells/well in 1 ml of this medium. Cells were incubated at 37°C in an atmosphere of 5 % COz in air. Medium was changed on days 4 and 7. Under these conditions, both types of chondrocytes and skin fibroblasts became confluent on day 9.
In designated experiments with articular chondrocytes, the day 7 medium change was to serum-free MCDB-104 supplemented with 100 ng/ml fibroblast growth factor, 5 pg/ml transferrin, 4 ng/ml sodium selenite, 2 pg/ml human fibronectin, and 1 mg/ ml pure albumin. Under these conditions, rabbit articular chondrocytes become confluent on day 12.
To measure [3H]thymidine incorporation, chondrocytes or skin fibroblasts grown in primary culture were treated according to Madsen et al. (14) . On day 7 of 10% FCS cultures and on day 10 of serum-free cultures, shortly before confluence, the medium was removed, the cells washed, and the medium replaced with serum-free MCDB-104 for 20 h. After this preincubation period, the medium was changed to fresh MCDB-104 containing either hGH at concentrations ranging between 20-200 ng/ml or buffer alone. Cells were then incubated for an additional 24 h. At 6 h before the end of incubation, [3H]thymidine 5 pCi/ml was added to quadruplicate flasks of each group. At the end of the incubation, the cells were washed three times with calcium and magnesium-free Gey's balanced salt solution followed by 0.5% Triton X 100. Chondrocytes or fibroblasts were collected on glass fiber filters which were dried and counted in 5 ml of fluor in a Packard (3-spectrometer (Hewlett-Packard Co., Palo Alto, CA).
Four additional identically treated flasks or wells from each group were not labeled with [3H]thymidine and were used for measurement of DNA content and cell number. Cells were trypsinized with 0.05% trypsin and 0.02% EDTA. An aliquot of the cell suspension was counted by hemocytometer; the remainder was used for DNA measurement according to Burton (28) for 25-cm2 flasks and according to Kapuscinski et al. (29) for 24-well plates.
Incorporation of [35S]sulfate into proteoglycans was assessed using chondrocytes grown to confluence in 24-well plates. In serum-free defined medium cultures, the incorporation was done on day 12. In 10% FCS cultures, the medium was changed to serum-free DMEM for 20 h on day 8. Cells were then incubated in serum-free, sulfate-free DMEM in the presence of 1.5 pCi/ml Na3%04 with or without hGH 100 ng/ml, or Sm-C/IGF-I 10 ng/ml. Control flasks contained the corresponding hormone buffers. After a further 6-and 20-h period of incubation at 37"C, the incorporation of [35S]sulfate into newly synthesized proteoglycans was measured in both culture medium and the cell layer as previously described (30) .
Proteoglycans were separately extracted from the medium and the cell layer at 4°C for 20 h with 3 M guanidinium hydrochloride in 0.5 Tris HCl, pH 7.4, and dialyzed against 8 M urea in 0.05 M Tris-HC1, pH 6.5. The nondialyzable fraction was chromatographed on a DEAE-cellulose column and sulfated proteoglycan subunits were eluted with 2 M NaC1. Aliquots of eluted material were added to fluor and counted in a Packard (3-spectrometer.
Counts were expressed as mean disintegrations per min per well (medium + cell layer) of six similarly treated wells. Data are reported as the mean k SEM. The hormone-treated cells are compared to control cells incubated with the corresponding buffer of each hormone used. Statistical significance was determined by Student's t test.
RESULTS
Bovine growth plate chondrocyte studies. When bovine growth plate chondrocytes cultured in serum-free medium were exposed to Sm-C/IGF-I, stimulation of [3H]thymidine incorporation reproducibly occurred at doses of 10 ng/ml or above ( p < 0.01). 7 8 TRIPPEL ET AL.
No stimulation occurred in the presence of hGH, bGH, or metrhGH at concentrations to 300 ng/ml. No stimulation or inhibition was observed in the presence of the buffer in which hGH was provided (Fig. 1) .
To determine whether the lack of response to growth hormone at these doses was due to a requirement for higher hormone levels, concentrations of hGH to 8 pglml and of bGH to 300 pg/ml were tested. No stimulation was obtained at any dose used (Fig. 2) .
To test the possibility that an early, transient stirnulatory effect of GH was being masked with this protocol (effect tested at 48 h), the time course of [3H]thymidine incorporation in the presence of Sm-C/IGF-I or of bGH was assessed. Sm-C/IGF-I 20 ng/ml produced an increase in [3H]thymidine incorporation which first appeared approximately 20 h after onset of exposure and progressed linearly over the 44-h duration of the experiments ( p < 0.01). Cells exposed to bGH 100 ng/ml showed no statistically significant difference from those incubated in the presence of serum-free medium alone O, > 0.4). To rule out bGH ineffectiveness due to degradation, utilization by cells, or a short half-life under the conditions of these studies, the time course of 13H]thymidine incorporation was reassessed by replacing medium with fresh medium every 2 h. Fresh medium contained the same additives as the original medium. This modification resulted in an enhancement of the Sm-C/IGF-I effect, but no unveiling of a bGH effect (Fig. 3) . To ensure that differences in label incorporation were not an artifact of solubilization and scintillation counting techniques, [3H]thymidine incorporation was assessed in replicate wells by whole mount autoradiography (see "Materials and Methods"). This technique produced the same results.
To evaluate the possibility that the observed absence of GHinduced stimulation reflected a time requirement for cellular response to GH greater than that for Sm-C/IGF-I, the duration of exposure to bGH or hGH was increased to 5 days. No stimulation of 13H]thymidine incorporation occurred.
It has been previously demonstrated that the different cell populations of the growth plate differ in their binding of Sm-C/ IGF-I (8) and in their response to Sm-C/IGF-I (9, 31) . It is thus possible that these populations differ with respect to responsiveness to GH as well. Because the above studies were conducted with cells derived from whole growth plates, it is possible that the response of a GH-sensitive population of cells was obscured or attenuated by dilution of this population among unresponsive cells. To assess this possibility, distal ulnar physes were separated into reserve and proliferative zones by microdissection, and cells of each zone were isolated as described in "Materials and Methods." Adequacy of zone separation was assessed by histologic analysis of separated zones. Histologic sections demonstrated that a thin region of reserve cells was consistently harvested with the proliferative zone and that contamination of reserve zone cells by proliferative zone cells did not occur. Neither bGH nor hGH influenced reserve zone cells at any dose tested (Fig. 4A) . The suggestion of slight stimulation of proliferative zone cells by GH at 3 ng/ml (Fig. 4B) was not reproducible in two further repetitions of this experiment. Incorporation of [3H]thymidine in the presence of bGH and hGH was not different from controls for either cell type. Stimulation of proliferative zone cells by Sm-C/IGF-I was more O, < 0.05) than of reserve zone cells. Cells from both reserve and proliferative zones were sensitive to Sm-C/IGF-I at concentrations as low as 3 ng/ml ( Fig. 4A and B) . When incubation medium was unchanged during the same time period (data not illustrated), control and bGH effects were superimposable on those shown, and maximal stimulation by Sm-C/IGF-I was half that illustrated. This level of stimulation was still significant (p < 0.01). To determine whether GH alters differentiated functions of chondrocytes not reflected in DNA synthetic activity, several of the above studies were repeated, testing the effect of GH on [35S] sulfate incorporation. Experiments were conducted as described for [3H]thymidine with the exception that 30 pCi/ml Na35S04 was added 4 h before termination of incubation. Incubation of bovine growth plate chondrocytes for 48 h or for 5 days resulted in marked stimulation of sulfate incorporation by Sm-C/IGF-I or fetal bovine serum, respectively. Separated proliferative zone chondrocytes showed a greater response (p < 0.01) to highly purified Sm-C/IGF-I than did reserve zone cells (Table 1) . In none of the experiments was bGH or hGH stimulatory over the 3-300 ng/ml dose range tested.
SM-CIIGF-I AND GH EFFECT ON CHONDROCYTES
Rabbit chondrocyte studies. When hGH 20-200 ng/ml was provided to rabbit articular and growth plate chondrocytes for 20 h, no effect was observed as measured by cell count, DNA content, or [3H]thymidine incorporation. In contrast, exposure of rabbit skin fibroblasts to hGH, 100 ng/ml for the same time period stimulated cell number by 13 1 % over control values (p < 0.05). DNA content of these cells was not significantly increased (Table 2 ). In addition, [3H]thymidine incorporation by rabbit articular chondrocytes exposed to hGH (all doses) was 595 & 34 cpm/pg DNA compared to 13,000 cpm/pg DNA for cells incubated with 5% FCS.
[3H]thymidine incorporation by rabbit growth plate chondrocytes was 842 + 88 cpm/pg DNA and 22,800 cpm/pg DNA for cells incubated with hGH and 5% FCS, respectively.
When articular chondrocytes were incubated in serum-free defined medium from day 7 to day 12 of primary culture, the addition of hGH 100 ng/ml to the culture medium (replenished every day for 5 days) did not affect cell multiplication (Table 3) .
On the contrary, a significant increase in cell number (p < 0.0 1) and DNA content (p < 0.05) was observed in Sm-C/IGF-Itreated versus control cells.
To determine whether GH or Sm-C/IGF-I stimulates differentiated activity of rabbit chondrocytes, the effects of hGH 100 ng/ml on [35S]sulfate incorporation was studied in comparison to Sm-C/IGF-I. As illustrated in Figure 5 , [35S]sulfate incorporation by both rabbit articular and growth plate chondrocytes was significantly stimulated by Sm-C/IGF-I after both 6 and 20 h of incubation. On the contrary, neither hGH nor met-rhGH was stimulatory at either time point.
When articular chondrocytes, incubated in serum-free MCDB-104 from day 7 until day 12, were exposed to [35S]sulfate for the final 20 h of this period in the presence or absence of the different hormones, hGH did not increase sulfate incorporation (Table 3) . In contrast, Sm-C/IGF-I stimulated sulfate incorporation 209% * Rabbit articular and growth plate chondrocytes and skin fibroblasts in serum-free culture were incubated in the presence or absence of bGH (100 ng/ml) for 20 h. At 6 h before the end of incubation [3H]thymidine, 5 pCi/ml, or no isotope was added and cell number, DNA content, and [3H]thymidine incorporation were assessed. Each value represents the mean + SEM of four flasks. t Significantly different from controls ( p < 0.05).
DISCUSSION
The mechanism by which GH exerts its effects on skeletal growth is incompletely understood. Many lines of evidence indicate that this effect is mediated by somatomedin, either in a classical endocrine fashion (1-6) or by an autocrine or paracrine mechanism (20, 21) . In addition, several recent reports have suggested a direct stimulation by GH (1 3-18 ). In the current studies, a direct effect of GH was sought in two tissues of particular significance to skeletal development: growth plate cartilage, the site of longitudinal skeletal growth, and articular cartilage, the cartilaginous component of joints.
Our data demonstrate that neither homologous nor heterologous GH stimulates either mitogenic or differentiated cell functions in bovine growth plate chondrocytes under a variety of experimental conditions. Similarly, rabbit articular and growth plate chondrocytes were unresponsive to either native or recombinant hGH.
The data further indicate that Sm-C/IGF-I stimulates both mitotic and differentiated cell functions in both physeal and articular chondrocytes. These effects are generated by nanomolar concentrations of Sm-C/IGF-I, a range consistent with a physiologic role in vivo.
The absence of chondrocyte stimulation in response to GH observed in our studies is in agreement with other recent studies (10, 12) that used embryonic avian (12) or fetal and adult human cartilage (10) under explant and clonal culture conditions. Our findings contrast with studies (14, 17) that used rabbit ear and rat rib growth chondrocytes under culture conditions reproduced in the present investigation. The apparent differences in these results may stem in part from differences in species (cow and rabbit versus rat) (1 4, 17), site of cartilage analyzed (limb versus rib) (14, 17) , and type of cartilage used (physeal and articular versus ear) (14) . In addition, the role of GH in early bovine development is not well established, and it is unknown to what degree the growth of young calves is GH dependent.
Reports addressing the ability of GH to stimulate cartilage may be divided into two categories according to their use of in vivo or in vitro conditions. SO-divided, such studies also tend to distribute according to the effect of GH on chondrocytes. Reports based on in vivo experiments are strikingly uniform in finding stimulation by GH of cartilage (13, 16, 19, 20, 32) . In contrast, reports of in vitro studies generally demonstrate lack of direct stimulation by GH (1, 2, 10, 12, 33) . This in vivo-in vitro dichotomy is consistent with the hypothesis that the effects of GH observed in vivo are dependent on mediating substances or cofactors available in vivo but not available under the in vitro conditions tested thus far. Although several such mediators may exist, currently available data suggests that Sm-C/IGF-I plays a central role.
Classically, the somatomedin hypothesis has viewed Sm-C/ IGF-I as an endocrine factor, circulating with its binding protein(~) (6) and participating in hypothalamic and pituitary feedback mechanisms (34) . More recent in vivo evidence suggests that the apparently direct stimulatory effect of GH on chondrocytes is mediated by local GH-dependent somatomedin production (20,2 1). Although such an autocrine or paracrine phenomenon might be expected to manifest itself in vitro in the presence of GH, the very low ratio of cell to medium volume under these conditions may dilute any GH-induced Sm-C/IGF-I to subthreshold levels. The present data are in accordance with the somatomedin hypothesis viewed either from a classical endocrine standpoint or from a paracrine/autocrine perspective.
We found that physeal chondrocytes from the proliferative zone were more responsive to Sm-C/IGF-I than their counterparts from the neighboring reserve zone. These data are consistent with the observation that proliferative zone cells have a greater Sm-C/IGF-I binding capacity than reserve zone cells (8) and with the demonstration in the rat that proliferative zone cells differ from other growth plate cells in their responsiveness to Sm-C/IGF-I (31). Taken together, these studies support a model in which the effect of Sm-C/IGF-I on the cell populations of the growth plate is dependent on the cell population's stage of maturational development.
The dual effector theory of GH action recently advanced by Green et al. (22) postulates that GH promotes precursor cell differentiation and that this differentiation renders the cells susceptible to clonal expansion under the influence of Sm-C/IGF-SM-C/IGF-I AND G H EFFECT ON CHONDROCYTES 8 1 I. The finding in the present studies that proliferative zone cells are more responsive to Sm-C/IGF-I, and in previous studies that these cells have a higher Sm-C/IGF-I binding capacity than reserve zone chondrocytes (8) , is consistent with this theory.
However, the present data also reveal that reserve zone chondrocytes, the presumed "germinal" cells of the growth plate, are capable of responding to Sm-C/IGF-I. This responsiveness would not be inconsistent with the dual effector theory if it reflects a differentiated state conferred on cells preexperimentally by GH in vivo, if certain reserve zone cells are not, in fact, stem cells, or if culture conditions alter their pattern of susceptibility. Nevertheless, these data suggest that the role of Sm-C/IGF-I in skeletal development is complex and may be diverse both in the cellular functions it regulates and the cell populations regulated. Further investigation will be required to define fully the relative importance of endocrine and paracrine/autocrine actions of Sm-C/ IGF-I on skeletal growth and its relationship to GH.
